Marinus Pharmaceuticals, Inc. (MRNS)

Marinus Pharmaceuticals Revenue

In the year 2023, Marinus Pharmaceuticals had annual revenue of $30.99M with 21.63% growth. Revenue in the quarter ending December 31, 2023 was $7.19M with 0.39% year-over-year growth.

• Revenue (ttm): $30.99M
• Revenue Growth: +21.63%
• P/S Ratio: 2.66
• Revenue / Employee: $187,812
• Employees: 165
• Market Cap: 82.51M USD

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	30.99M	5.51M	21.63%
Dec 31, 2022	25.48M	10.13M	66.03%
Dec 31, 2021	15.35M	13.63M	793.19%
Dec 31, 2020	1.72M	-	-
Dec 31, 2019	0	-	-
Dec 31, 2018	0	-	-
Dec 31, 2017	0	-	-
Dec 31, 2016	0	-	-
Dec 31, 2015	0	-	-
Dec 31, 2014	0	-	-
Dec 31, 2013	0	-	-
Dec 31, 2012	100.00K	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.